查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1511796

基於透明質酸的真皮填充劑市場規模、佔有率和趨勢分析報告：按應用、按產品、按地區和細分市場預測，2024-2030 年

Hyaluronic Acid-based Dermal Fillers Market Size, Share & Trends Analysis Report By Application (Wrinkle Removal, Lip Augmentation, Rhinoplasty), By Product, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10個工作天內

價格

基於透明質酸的真皮填充劑市場成長與趨勢：

根據Grand View Research, Inc.最新報告預測，到2030年，全球透明質酸皮下填充劑市場規模預計將達到82.4億美元，2024年至2030年複合年成長率為10.5%。

對微創手術的需求不斷增加、老年人口不斷增加、對年輕皮膚的認知和興趣不斷增強以及技術進步是推動市場成長的關鍵因素。

全球人口老化正在加劇。到2030年，全球六分之一的人將超過60歲，老年人口將從11億增加到14億。在美國，預計到2060年，四分之一的人口將年齡在65歲或以上。目前，世界60歲及以上人口三分之二生活在中等收入國家，中等收入國家正在發生重大變化。

然而，高昂的市場成本限制了市場機會。基於 HA 的真皮填充劑有 1 毫升注射器可供選擇，每個注射器的價格為 600-1,000 美元。大多數情況下，至少需要2個注射器，治療費用相當高，達到1600-2000美元。產品成本高昂，讓低收入和中等收入國家的人難以負擔。

基於透明質酸的真皮填充劑市場報告亮點

  • 單相產品細分市場佔最大收益佔有率，2023 年為 54.76%。
  • 從應用來看，除皺領域以2023年最大的銷售佔有率29.53%引領市場。這是由於整容手術支出的增加以及使用透明質酸填充劑的除皺技術的出現。除皺是最常見的皮膚問題，導致該領域的需求增加。
  • 北美以 2023 年最大的銷售佔有率主導市場。例如，根據加拿大統計局2021年9月發布的人口統計數據，加拿大60歲及以上的人口總數為96,88,677人。
  • 由於日本、中國和韓國等國家經濟的快速成長以及該地區醫療基礎設施的改善，預計亞太市場在預測期內將以最快的複合年成長率成長。
  • 艾爾建（AbbVie）是全球市場的主要企業之一。這是由於該公司基於 HA 的真皮填充劑 Juvederm 的長期市場佔有率以及儘管推出了新產品但該產品的高性能。該公司擁有強大的透明質酸真皮填充劑產品系列，致力於將創新產品推向市場。

目錄

第1章基於透明質酸的真皮填充劑市場：調查方法和範圍

第2章基於透明質酸的真皮填充劑市場：執行摘要

  • 市場展望
  • 分部展望
  • 競爭考察

第3章以透明質酸為基礎的真皮填充劑市場：變數、趨勢、範圍

  • 市場體系展望
  • 市場動態
  • 商業環境分析工具
  • 定性分析：COVID-19 對透明質酸真皮填充劑市場的影響

第4章 透明質酸真皮填充劑市場：產品評估與趨勢分析

  • 基於透明質酸的真皮填充劑市場：產品儀表板
  • 基於透明質酸的真皮填充劑市場：產品變化分析
  • 2018-2030年基於玻尿酸的真皮填充劑市場規模、預測與趨勢分析（依產品）
  • 單相產品
  • 雙相產品

第5章 透明質酸真皮填充劑市場：應用估算與趨勢分析

  • 基於透明質酸的真皮填充劑市場：應用儀表板
  • 透明質酸真皮填充劑市場：應用變化分析
  • 2018-2030年基於玻尿酸的真皮填充劑市場規模、預測與趨勢分析（依應用）
  • 除皺
  • 豐唇術
  • 鼻整形術
  • 其他

第6章基於透明質酸的真皮填充劑市場：區域估計和趨勢分析

  • 基於透明質酸的真皮填充劑市場：區域儀表板
  • 2018-2030年市場規模及預測趨勢分析
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商情況
    • Key company market share analysis, 2023
    • Allergan;Galderma Laboratories
    • Merz Pharmaceuticals
    • Genzyme Corporation
    • Anika Therapeutics Inc.
    • LG Life Sciences
    • LTD（LG Chem）
    • Bio plus Co. Ltd.
    • Sculpt Luxury
    • Dermal Fillers Ltd.
    • Bioxis Pharmaceutical
    • Sinclair Pharma;Laboratories
    • Vivacy;Bohus Biotech AB
Product Code: GVR-2-68038-999-9

Hyaluronic Acid-based Dermal Fillers Market Growth & Trends:

The global hyaluronic acid-based dermal fillers market size is anticipated to reach at USD 8.24 billion by 2030 and is projected to grow at a CAGR of 10.5% from 2024 to 2030, based on a new report by Grand View Research, Inc. The increasing demand for minimally invasive procedures, growing geriatric population, increasing awareness & concern for younger skin and advancement in technology are key factors driving the market growth.

The global ageing population is increasing. By 2030, 1 in 6 persons globally will be above 60 years old or over with total elder population growing from one 1 to 1.4 billion. In the U.S., it is estimated that one fourth of the people will be above 65 by 2060. Currently the middle-income countries are witnessing huge change with two-thirds of global population over 60 years would be from middle-income countries.

However, the higher cost of market is restraining the market opportunities. The HA-based dermal fillers are available in syringes of 1ml costing USD 600-1000 per syringe. Most of the times a dosage of minimum 2 syringes is required, taking the cost of treatment to USD 1600-2000 which is quite high. The high cost of products makes it difficult for the population of low- medium-income countries.

Hyaluronic Acid-based Dermal Fillers Market Report Highlights:

  • The single-phase products segment held the market with the largest revenue share of 54.76% in 2023, owing to the benefits like better effectiveness & offered by these products
  • Based on application, the wrinkle removal segment led the market with the largest revenue share of 29.53% in 2023. This can be attributed to the increasing spending on cosmetic procedures and the advent of technology for Wrinkle Removal suing HA-based fillers. Wrinkle Removal is the most common skin problems, resulting higher demand for the segment
  • North America dominated the market with the largest revenue share of in 2023. This can be attributed to favorable government policies, a rise in the number of plastic surgery procedures and an growing ageing population in the region For instance, as per the Statistics Canada's population statistics published in September 2021, the total population above 60 years of age in Canada is 96, 88,677
  • The Asia Pacific market is expected to grow at the fastest CAGR during the forecast period, owing to the rapid economic growth in nation like Japan, China & South Korea and improvement in healthcare infrastructure in the region
  • Allergan (AbbVie), is a one of the major global market leaders. This can be attributed to market presence of Juvederm, a HA based dermal filler by the company for long time and better performance of product despite new products being introduced. The company's has powerful product portfolio of HA based dermal fillers & focuses on introducing innovative products into in market

Table of Contents

Chapter 1 Hyaluronic Acid-based Dermal Fillers Market: Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Product
    • 1.1.2 Application
    • 1.1.3 Regional Scope
    • 1.1.4 Estimates and Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
  • 1.7 List of Secondary Sources
  • 1.8 List of Abbreviations
  • 1.9 Objectives
    • 1.9.1 Objective 1
    • 1.9.2 Objective 2
    • 1.9.3 Objective 3

Chapter 2 Hyaluronic Acid-based Dermal Fillers Market: Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
    • 2.2.1 Product
    • 2.2.2 Application
    • 2.2.3 Region
  • 2.3 Competitive Insights

Chapter 3 Hyaluronic Acid-based Dermal Fillers Market: Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
      • 3.2.1.1 Growing Aging Population
      • 3.2.1.2 Increasing Awareness and Acceptance of Aesthetic Treatments
      • 3.2.1.3 Technological Advancements
    • 3.2.2 Market Restraint Analysis
    • 3.2.3 Regulatory Contraints
    • 3.2.4 High Cost of Procedures
  • 3.3 Business Environment Analysis Tools
    • 3.3.1 Porter's five forces analysis
      • 3.3.1.1 Bargaining power of buyers: Low
      • 3.3.1.2 Bargaining power of suppliers: Moderate
      • 3.3.1.3 Competitive Rivalry: High
      • 3.3.1.4 Threat of new entrants: Moderate
      • 3.3.1.5 Threat of substitutes: Low
    • 3.3.2 SWOT Analysis, by PESTEL
      • 3.3.2.1 Political & legal
      • 3.3.2.2 Economic
      • 3.3.2.3 Technological
  • 3.4 Qualitative Analysis: Impact of COVID-19 on Hyaluronic Acid-based Dermal Fillers Market Market

Chapter 4. Hyaluronic Acid-based Dermal Fillers Market: Product Estimates & Trend Analysis

  • 4.1. Hyaluronic Acid-based Dermal Fillers Market: Product Dashboard
  • 4.2. Hyaluronic Acid-based Dermal Fillers Market: Product Movement Analysis
  • 4.3. Hyaluronic Acid-based Dermal Fillers Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Single-Phase Product
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Duplex Product
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Hyaluronic Acid-based Dermal Fillers Market: Application Estimates & Trend Analysis

  • 5.1. Hyaluronic Acid-based Dermal Fillers Market: Application Dashboard
  • 5.2. Hyaluronic Acid-based Dermal Fillers Market: Application Movement Analysis
  • 5.3. Hyaluronic Acid-based Dermal Fillers Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Wrinkle Removal
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Lip Augmentation
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Rhinoplasty
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Hyaluronic Acid-based Dermal Fillers Market: Regional Estimates & Trend Analysis by Country, Type & Therapy

  • 6.1. Hyaluronic Acid-based Dermal Fillers Market: Regional Dashboard
  • 6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
  • 6.3. North America
    • 6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.9. Denmark
      • 6.4.9.1. Key country dynamics
      • 6.4.9.2. Regulatory framework/ reimbursement structure
      • 6.4.9.3. Competitive scenario
      • 6.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.3. Japan
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.5. Australia
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.7. South Korea
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework/ reimbursement structure
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.3. Mexico
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.4. Argentina
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.3. South Africa
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key company market share analysis, 2023
    • 7.3.2. Allergan; Galderma Laboratories
      • 7.3.2.1. Company overview
      • 7.3.2.2. Financial performance
      • 7.3.2.3. Type benchmarking
      • 7.3.2.4. Strategic initiatives
    • 7.3.3. Merz Pharmaceuticals
      • 7.3.3.1. Company overview
      • 7.3.3.2. Financial performance
      • 7.3.3.3. Type benchmarking
      • 7.3.3.4. Strategic initiatives
    • 7.3.4. Genzyme Corporation
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Type benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Anika Therapeutics Inc.
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Type benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. LG Life Sciences
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Type benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. LTD (LG Chem)
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Type benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Bio plus Co. Ltd.
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Type benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Sculpt Luxury
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Type benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Dermal Fillers Ltd.
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Type benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Bioxis Pharmaceutical
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Type benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Sinclair Pharma; Laboratories
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Type benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. Vivacy; Bohus Biotech AB
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Type benchmarking
      • 7.3.13.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modelling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market outlook
  • Fig. 8 Hyaluronic acid-based dermal fillers market segmentation
  • Fig. 9 Penetration & growth prospect mapping
  • Fig. 10 Market trends & outlook
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Hyaluronic acid-based dermal fillers product market share analysis, 2023 & 2030
  • Fig. 14 Hyaluronic acid-based dermal fillers product market: Segment dashboard
  • Fig. 15 Single-phase product market estimates and forecast, 2018 - 2030
  • Fig. 16 Duplex product market estimates and forecast, 2018 - 2030
  • Fig. 17 Hyaluronic acid-based dermal fillers application market share analysis, 2023 & 2030
  • Fig. 18 Hyaluronic acid-based dermal fillers application market: Segment dashboard
  • Fig. 19 Wrinkle removal market estimates and forecasts, 2018 - 2030
  • Fig. 20 Lip augmentation market estimates and forecasts,2018 - 2030
  • Fig. 21 Rhinoplasty market estimates and forecasts, 2018 - 2030
  • Fig. 22 Others market estimates and forecasts, 2018 - 2030
  • Fig. 23 Hyaluronic acid-based dermal fillers regional market share analysis, 2023 & 2030
  • Fig. 24 Hyaluronic acid-based dermal fillers regional market: Segment dashboard
  • Fig. 25 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Company market position analysis.